Yes—machines that support the lungs outside the body are an established treatment for selected people with severe lung distress. A 2026 review in *Intensive Care Medicine* looks at these treatments. It marks 60 years since the description of acute respiratory distress syndrome. This is a serious condition that makes breathing difficult. The review covers people receiving machine-based lung support, not healthy people tracking routine bloodwork. The authors discuss machines that support oxygen delivery and remove carbon dioxide. They also cover devices focused on removing carbon dioxide alone. The review examines how well these treatments work, daily care, and possible complications. It also looks at factors linked to recovery and survivors’ long-term health. The supplied summary gives no treatment success rates or changes in blood levels. It describes established use in selected patients while noting unanswered questions. Ongoing studies aim to clarify how this support should be used. That means this source offers a broad overview, not a new numerical finding. For our Carbon Dioxide (CO2 / Bicarbonate) community, the distinction matters. Your routine bloodwork marker measures bicarbonate, which helps keep blood from becoming too acidic. This review is about intensive care support, not a target for that marker. It does not test everyday habits or ways to improve routine results. When comparing numbers on BioSocial, context can keep the discussion useful. Sharing trends alongside changes in routines gives peers more than one isolated result. It also helps separate everyday tracking from hospital treatment research. What patterns have you noticed in your results over time, and what context do you share alongside them?